Elly A. Hassink

2.1k citations

31 papers · 994 indexed · h-index 17

Co-authors: C Festen Paul N.M.A. Rieu Peter Reiss K. Visser Cor J. Kalkman Gouke J. Bonsel Michiel A. van Agtmael Sven A. Danner
Topics: HIV/AIDS drug development and treatment (18 papers)HIV Research and Treatment (16 papers)HIV-related health complications and treatments (10 papers)
Cited by: Virology Emergency Medicine Anesthesiology and Pain Medicine
Journals: PLoS ONE Clinical Infectious Diseases Annals of Surgery
Partner nations: Netherlands Thailand Australia

In The Last Decade

Elly A. Hassink

29 papers receiving 948 citations

Peers

Countries citing papers authored by Elly A. Hassink

Since Specialization

Citations

This map shows the geographic impact of Elly A. Hassink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elly A. Hassink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elly A. Hassink more than expected).

Fields of papers citing papers by Elly A. Hassink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elly A. Hassink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elly A. Hassink. The network helps show where Elly A. Hassink may publish in the future.

Co-authorship network of co-authors of Elly A. Hassink

This figure shows the co-authorship network connecting the top 25 collaborators of Elly A. Hassink. A scholar is included among the top collaborators of Elly A. Hassink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elly A. Hassink. Elly A. Hassink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial 2020 ·Nutrients ·Jean‐Charles Picaud,(unknown),Małgorzata Arciszewska,(unknown),Joaquín Escribano,(unknown),(unknown),Elly A. Hassink,Anneke Rijnierse,Marieke Abrahamse‐Berkeveld,Bartosz Korczowski,(unknown)	13
2	Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Marit G. A. van Vonderen,Regje M. E. Blümer,Elly A. Hassink,Jussi Sutinen,Mariëtte T. Ackermans,Michiel A. van Agtmael,Hannele Yki‐Järvinen,Sven A. Danner,Mireille J. Serlie,Hans P. Sauerwein,Peter Reiss	19
3	First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir 2009 ·AIDS ·(unknown),Paul Lips,Michiel A. van Agtmael,Elly A. Hassink,Kees Brinkman,Suzanne E. Geerlings,Jussi Sutinen,Matti Ristola,Sven A. Danner,Peter Reiss	83
4	Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production 2009 ·Arteriosclerosis Thrombosis and Vascular Biology ·Remco Franssen,Raaj R. Sankatsing,Elly A. Hassink,Barbara A. Hutten,Mariëtte T. Ackermans,Kees Brinkman,(unknown),Alejandro Arenas‐Pinto,Stephen P. Storfer,John J.P. Kastelein,Hans P. Sauerwein,Peter Reiss,Erik S.G. Stroes	34
5	HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance 2008 ·Journal of Viral Hepatitis ·(unknown),Nening M. Nanlohy,Charlotte H. S. B. van den Berg,Elly A. Hassink,Marcel Beld,Teus van Laar,Sylvia M. Bruisten,Ferdinand Wit,Anneke Krol,Maria Prins,Joep M. A. Lange,D. van Baarle	16
6	Brief Report: Stavudine but not Didanosine as Part of HAART Contributes to Peripheral Lipoatrophy: A Substudy from the Antiretroviral Regimen Evaluation Study (ARES) 2007 ·HIV Clinical Trials ·(unknown),Elly A. Hassink,Berthe L.F. van Eck‐Smit,Jan C.C. Borleffs,Joep M. A. Lange,Peter Reiss	10
7	Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients 2007 ·AIDS ·Reshma Autar,Ferdinand W N M Wit,(unknown),(unknown),(unknown),Elly A. Hassink,Andrew Hill,David A. Cooper,Praphan Phanuphak,Joep MA Lange,David M. Burger,Kiat Ruxrungtham	8
8	A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 Infection 2005 ·Clinical Infectious Diseases ·Peter Cardiello,Elly A. Hassink,Jintanat Ananworanich,Preeyaporn Srasuebkul,(unknown),Apicha Mahanontharit,Kiat Ruxrungtham,B Hirschel,Joep M. A. Lange,Praphan Phanuphak,D. A. Cooper	48
9	Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients 2005 ·Journal of Antimicrobial Chemotherapy ·Reshma Autar,Marta Boffito,Elly A. Hassink,Ferdinand W N M Wit,Jintanat Ananworanich,Umaporn Siangphoe,Anton Pozniak,David A. Cooper,Praphan Phanuphak,Joep M. A. Lange,Kiat Ruxrungtham,David M. Burger	29
10	Comparison of Two Once-Daily Regimens with a Regimen Consisting of Nelfinavir, Didanosine, and Stavudine in Antiretroviral Therapy-Naïve Adults: 48-Week Results from the Antiretroviral Regimen Evaluation Study (ARES) 2005 ·HIV Clinical Trials ·S.H. Lowe,Annemarie M. J. Wensing,Elly A. Hassink,Reinier W. ten Kate,Clemens Richter,Gerrit Schreij,P.P. Koopmans,J.R. Juttmann,Ingeborg van der Tweel,Joep M. A. Lange,Jan C.C. Borleffs	6
11	The 48‐week efficacy of once‐daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy 2005 ·HIV Medicine ·Peter Cardiello,Preeyaporn Srasuebkul,Elly A. Hassink,Apicha Mahanontharit,(unknown),Kiat Ruxrungtham,Joep M. A. Lange,David A. Cooper,Praphan Phanuphak	11
12	Dose-Escalating Study of the Safety and Pharmacokinetics of Nelfinavir in HIV-Exposed Neonates 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Chokechai Rongkavilit,Rolf P. G. van Heeswijk,Sompop Limpongsanurak,(unknown),(unknown),Elly A. Hassink,(unknown),Theshinee Chuenyam,Sasiwimol Ubolyam,Richard M. W. Hoetelmans,Kiat Ruxrungtham,Joep M. A. Lange,David A. Cooper,Praphan Phanuphak	13
13	Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Peter Cardiello,(unknown),Elly A. Hassink,Preeyaporn Srasuebkul,Apicha Mahanontharit,(unknown),(unknown),Jos H. Beijnen,Richard M. W. Hoetelmans,Kiat Ruxrungtham,David A. Cooper,Joep M. A. Lange,Praphan Phanuphak	44
14	Parenting children with anorectal malformations: implications and experiences 1998 ·Pediatric Surgery International ·Elly A. Hassink,(unknown),(unknown),Paul N.M.A. Rieu,(unknown),(unknown),C Festen	31
15	Adults born with high anorectal atresia—How do they manage? 1996 ·Diseases of the Colon & Rectum ·Elly A. Hassink,Paul N.M.A. Rieu,R.S.V.M. Severijnen,(unknown),C Festen	9
16	Additional congenital defects in anorectal malformations 1996 ·European Journal of Pediatrics ·Elly A. Hassink,Paul N.M.A. Rieu,Ben C.J. Hamel,R.S.V.M. Severijnen,(unknown),C Festen	64
17	Quality of life after operatively corrected high anorectal malformation: A long-term follow-up study of patients aged 18 years and older 1994 ·Journal of Pediatric Surgery ·Elly A. Hassink,Paul N.M.A. Rieu,(unknown),C Festen	63
18	Are Adults Content or Continent After Repair for High Anal Atresia? A Long-term Follow-up Study in Patients 18 Years of Age and Older 1993 ·Annals of Surgery ·Elly A. Hassink,Paul N.M.A. Rieu,R.S.V.M. Severijnen,(unknown),C Festen	37
19	Pulmonary morbidity 10–18 years after irradiation for Hodgkin's disease 1993 ·European Journal of Cancer ·Elly A. Hassink,(unknown),Liesbeth Boersma,(unknown),Rein Melkert,Nico van Zandwijk,Joos V. Lebesque,Peter F. Bruning	20
20	Thyroid function 10–18 years after mantle field irradiation for Hodgkin's disease 1992 ·European Journal of Cancer ·(unknown),Elly A. Hassink,Rein Melkert,L. Dewit,W J Nooijen,Peter F. Bruning	22

About Elly A. Hassink

Elly A. Hassink is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 31 papers that have together received 994 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (16 papers) and HIV-related health complications and treatments (10 papers). The work is most often cited by research in Virology (292 citations), Emergency Medicine (332 citations) and Anesthesiology and Pain Medicine (114 citations). Elly A. Hassink has collaborated with scholars based in Netherlands, Thailand and Australia. Frequent co-authors include C Festen, Paul N.M.A. Rieu, Peter Reiss, K. Visser, Cor J. Kalkman, Gouke J. Bonsel, Michiel A. van Agtmael, Sven A. Danner, R.S.V.M. Severijnen and Joep M. A. Lange. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact